Clinical trial

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1

NCT04271228

Study summary

ClinicalTrials.gov

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention DreaMed Advisor Pro Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-15

PhaseNA

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

DreaMed Advisor ProDEVICE

Sponsors & collaborators

Rabin Medical Centerlead sponsor

Mapped research locations

Petah TikvaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04271228 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.